Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an announcement.
Recordati has released the summary report of the voting results from its Ordinary Shareholders’ Meeting held on April 29, 2025. This report is accessible on the company’s website and through an authorized storage mechanism, reflecting the company’s commitment to transparency and shareholder engagement.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, and operates across 150 countries in the EMEA, Americas, and APAC regions with over 4,450 employees.
YTD Price Performance: -2.73%
Average Trading Volume: 25,406
Technical Sentiment Signal: Sell
Current Market Cap: €10.12B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.